Psychedelic replications in virtual reality and their potential as a therapeutic instrument: an open-label feasibility study.
Karl Kristjan Kaup, Madis Vasser, Kadi Tulver, Mari Munk, Juhan Pikamäe, Jaan Aru
Front Psychiatry March 1, 2023 DOI: 10.3389/fpsyt.2023.1088896 via PubMed Central
Summary
AI-generated from the abstractAn open-label feasibility study tested whether a virtual reality simulation designed to replicate aspects of the psychedelic experience could be used as a therapeutic tool. Participants reported that the VR experience produced subjective effects resembling those of psychedelics, including altered perception and a sense of oceanic boundlessness. The findings suggest that VR-based psychedelic replications are feasible and acceptable, and may offer a scalable, non-pharmacological approach for mental health interventions. The study did not assess clinical outcomes, but participants showed reduced negative affect after the session. The authors indicate that further controlled research is needed to determine therapeutic efficacy.
Study at a glance
| Characteristics | Open-label feasibility study Peer reviewed |
|---|---|
| Sample size | 10 |
| Population | Healthy participants |
| Duration | Single session |
| Keywords | Virtual-reality Psychedelics Mental-health Consciousness-research Therapeutic-technology |
| Citations | 22 |
| Key finding | Virtual reality simulations replicating psychedelic experiences are feasible and acceptable, and may reduce negative affect in participants. |
Abstract
Psychedelic replications in virtual reality and their potential as a therapeutic instrument: an open-label feasibility study.